Global Voltaren Market Size, Share and Trends Analysis Report, By Type (Oral, Parental and Topical) By Indication (Rheumatoid Arthritis, Migraine, Pain, and Others), Forecast Period (2022-2028)

The global Voltaren market is anticipated to grow at a CAGR of 3.2% during the forecast period (2022-2028). During the projected period, there is expected to be a high demand for better and novel anti-inflammatory treatments with fewer side effects and improved efficacy, resulting in multiple potentials for market expansion. Patients who have chronic pain that is rated at least 50% on the visual analog scale are eligible for high-potency opioid treatment. Voltaren can be used in conjunction with co-Voltaren, such as sedatives, antidepressants, and anti-epileptics, at any stage of pain management, potentially lowering Voltaren drug doses. The Voltaren range includes oral (tablet and liquid capsules) and topical (applied to the skin) treatments.

 

Voltaren is a white or slightly yellowish crystalline powder that is a non-steroidal anti-inflammatory medication. It is used to treat arthritis-related pain, edema, and joint stiffness. It is only available with a prescription and comes in the form of tablets, capsules, and suppositories. Pharmacy gels and plasters for joint discomfort are available. Voltaren is most commonly used to treat arthritis and inflammatory pain from surgery or injury. The Voltaren market is being driven by an aging population and surgical practices. Over the age of 50, 70% of the population suffers from musculoskeletal disorders. Arthritis affects more than 350 million people globally.

 

Some major players in the market include Endo International plc, Enovachem Pharmaceuticals, GlaxoSmithKline plc, Ancalima Lifesciences Ltd, and Novartis AG among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

 

Companies and their Product Portfolio

• Novartis AG offers Voveran SR 100 Tablet, It is a stimulant pain reliever. It’s used to treat rheumatoid arthritis, osteoarthritis, and acute musculoskeletal injuries, as well as discomfort, swelling, stiffness, and joint soreness. Back discomfort, shoulder pain, neck pain, sprains, and spasms are all popular uses.
• GlaxoSmithKline plc. offers Voltaren Emulgel, Voltaren Gel is a nonsteroidal anti-inflammatory medication (NSAID) that is used to treat osteoarthritis joint pain. Diclofenac is the main ingredient in Voltaren. Diclofenac works by decreasing pain and inflammation-causing chemicals in the body. Voltaren Gel is used to relieve joint discomfort in the hands, wrists, elbows, knees, ankles, and feet caused by osteoarthritis. Voltaren Gel is a non-greasy, smooth gel with a mild scent that fades quickly after application.
• Ancalima Lifesciences Ltd offers Voltaron 75mg Injection, it is a narcotic pain reliever. It’s used to treat rheumatoid arthritis, osteoarthritis, and acute musculoskeletal injuries, as well as discomfort, edema, stiffness, and joint soreness. When oral administration is not practicable, it is given.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Indication
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

• Competitive Landscape- Endo International plc, Enovachem Pharmaceuticals, GlaxoSmithKline plc, Ancalima Lifesciences Ltd, Novartis AG among others.

 

Key questions addressed by the report

 

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Voltaren Market Report by Segment

By Type

• Oral
• Topical
• Parental

 

By Indication

• Rheumatoid Arthritis
• Migraine
• Pain
• Others (Osteoarthritis, Dysmenorrhea)

 

Global Voltaren Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa